Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
All miscellaneous studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchSelect treatment..Select..
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

Recent:   

Screening Commercial Tea for Rapid Inactivation of Infectious SARS-CoV-2 in Saliva

Morris et al., Food and Environmental Virology, doi:10.1007/s12560-023-09581-0
Jan 2024  
  Post
  Facebook
Share
  Source   PDF  
In Vitro study showing that certain teas can rapidly inactivate SARS-CoV-2 in saliva. At 10 mg/mL infusion, black tea showed the highest reduction (99.9%) of infectious SARS-CoV-2 within 10 seconds. Green, mint medley, eucalyptus mint, and raspberry zinger teas showed 96-99% inactivation at the same concentration. At 40 mg/mL infusions, all five teas inactivated 99.9% of the virus within 10 seconds. Tea polyphenol content, but not pH, significantly correlated with virus reduction. The teas also exhibited preventive effects against SARS-CoV-2 infection of Vero-E6 cells when added before (68-90% reduction), during (99-99.9% reduction), or after (94-98% reduction) virus infection, with the strongest inhibition observed when teas were added at the time of infection. Authors suggest that drinking or gargling tea could be a rapid at-home intervention to reduce infectious SARS-CoV-2 load in the oral cavity and potentially mitigate infection of the oral mucosa.
Morris et al., 31 Jan 2024, peer-reviewed, 2 authors.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperMiscellaneousAll
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit